export const featuredFunds = {
  "open_end": [
    {
      "fund_code":406,
      "fundshortname":"Gabelli Growth Fund AAA",
      "end_price":"74.33",
      "ttl_return":0.1292920085,
      "objective":"Invests in a diversified portfolio of common stocks that have favorable, yet undervalued, prospects for earnings growth and price appreciation. The Fund's primary objective is to seek capital appreciation by employing an earnings-driven investment approach. \r\n",
      "ticker_sym":"GABGX",
      "fund_type":"Open End",
      "doc_links": {
        "factsheet":"https://gab-factsheets.s3.us-east-2.amazonaws.com/1Q20GabelliGrowth03312020.pdf",
        "prospectus":"https://gab-prospectus.s3.us-east-2.amazonaws.com/GabelliGrowth_2020_Pro_WebReady04292020.pdf",
        "annual_report":"https://gab-annual-reports.s3.us-east-2.amazonaws.com/GB11GrowthAnnual1212312019.pdf"
      },
      "end_date":"2020-06-10T00:00:00.000Z"
    },
    {
      "fund_code":408,
      "fundshortname":"Gabelli ABC Fund AAA",
      "end_price":"10.03",
      "ttl_return":-0.0176297747,
      "objective":"Invests in securities the investment advisor believes provide attractive opportunities for appreciation or investment income. The Fund's primary objective is to achieve total returns that are attractive to investors in various market conditions without excessive risk of capital loss. \r\n",
      "ticker_sym":"GABCX",
      "fund_type":"Open End",
      "doc_links": {
        "factsheet":"https://gab-factsheets.s3.us-east-2.amazonaws.com/1Q20GabelliABC03312020.pdf",
        "prospectus":"https://gab-prospectus.s3.us-east-2.amazonaws.com/InvestorABC-PRO2020-WedReadyv204302020.pdf",
        "annual_report":"https://gab-annual-reports.s3.us-east-2.amazonaws.com/GB29ABCAnnual1212312019.pdf"
      },
      "end_date":"2020-06-10T00:00:00.000Z"
    },
    {
      "fund_code":2994,
      "fundshortname":"Gabelli Pet Parents Fund I",
      "end_price":"11.32",
      "ttl_return":0.1308691308,
      "objective":"Under normal market conditions, the Fund invests at least 80% of its net assets, plus borrowings for\r\ninvestment purposes, in common and preferred shares of publicly traded domestic and foreign companies\r\nof all capitalization ranges in the pet industry. The pet industry includes companies that offer services and\r\nproducts for pets and pet owners (“Pet Parents”). Such companies will generally derive at least 50% of their\r\nrevenues or profits from, or will devote at least 50% of their assets to the following sectors: manufacturers\r\nand distributors of pet food, pet supplies, veterinary pharmaceuticals, veterinary wellness, veterinary and\r\nother pet services, pet equipment, pet toys, and products and services that support Pet Parents regarding\r\ntheir pet activities (hereinafter the “Pet Industry”).",
      "ticker_sym":"PETZX",
      "fund_type":"Open End",
      "doc_links": {
        "factsheet":"https://gab-factsheets.s3.us-east-2.amazonaws.com/4Q19GabelliPetParents12312019.pdf",
        "prospectus":"https://gab-prospectus.s3.us-east-2.amazonaws.com/InnovationsTrustPRO_WebReady01282020.pdf",
        "annual_report":"https://gab-annual-reports.s3.us-east-2.amazonaws.com/GB68PetParentsAnnual0909302019.pdf"
      },
      "end_date":"2020-06-10T00:00:00.000Z"
    }
  ],
  "closed_end":[
    {
      "fund_code":-117,
      "fundshortname":"The GDL Fund",
      "end_price":"10.62",
      "ttl_return":-0.0368558725,
      "objective":"The Fund is a diversified, closed-end management investment company whose investment objective is to achieve absolute returns in various market conditions without excessive risk of capital. Absolute returns are defined as positive total returns, regardless of the direction of securities markets. To achieve its investment objective, the Fund, under normal market conditions, will invest primarily in\r\nsecurities of companies (both domestic and foreign) involved in publicly announced mergers, takeovers, tender offers and leveraged buyouts and, to a lesser extent, in corporate reorganizations involving stubs, spin-offs, and liquidations.",
      "ticker_sym":"GDL",
      "fund_type":"Closed End",
      "doc_links": {
        "factsheet":"https://gab-factsheets.s3.us-east-2.amazonaws.com/GDLQ1202003312020.pdf",
        "prospectus":"https://gab-prospectus.s3.us-east-2.amazonaws.com/-117.pdf",
        "annual_report":"https://gab-annual-reports.s3.us-east-2.amazonaws.com/GB39GDLAnnual1212312019.pdf"
      },
      "legalname2":"The GDL Fund",
      "end_date":"2020-06-10T00:00:00.000Z"
    },
    {
      "fund_code":-124,
      "fundshortname":"Ellsworth Growth and Income Fund Ltd.",
      "end_price":"12.23",
      "ttl_return":0.0438514504,
      "objective":"Ellsworth Growth and Income Fund Ltd. operates as a closed-end, diversified management investment company and invests primarily in convertible securities and common stock, with the objectives of providing income and the potential for capital appreciation; which objectives the Fund considers to be relatively equal, over the long-term, due to the nature of the securities in which it invests. ",
      "ticker_sym":"ECF",
      "fund_type":"Closed End",
      "doc_links": {
        "factsheet":"https://gab-factsheets.s3.us-east-2.amazonaws.com/ECFQ1202003312020.pdf",
        "prospectus":null,
        "annual_report":"https://gab-annual-reports.s3.us-east-2.amazonaws.com/GB45ECFAnnual0909302019.pdf"
      },
      "legalname2":"Ellsworth Growth \u0026 Income Fund Ltd.",
      "end_date":"2020-06-10T00:00:00.000Z"
    },
    {
      "fund_code":-118,
      "fundshortname":"Healthcare and Wellness\u003cSUP\u003eRx\u003c/SUP\u003e Trust",
      "end_price":"12.36",
      "ttl_return":-0.0421620628,
      "objective":"The Gabelli Healthcare \u0026 Wellness Rx Trust is a closed-end, diversified management investment company whose investment objective is long-term growth of capital. The Fund seeks opportunities for long-term growth presented in the healthcare and wellness industries.",
      "ticker_sym":"GRX",
      "fund_type":"Closed End",
      "doc_links": {
        "factsheet":"https://gab-factsheets.s3.us-east-2.amazonaws.com/GRXQ1202003312020.pdf",
        "prospectus":"https://gab-prospectus.s3.us-east-2.amazonaws.com/-118.pdf",
        "annual_report":"https://gab-annual-reports.s3.us-east-2.amazonaws.com/GB38GRXAnnual1212312019.pdf"
      },
      "legalname2":"The Gabelli Healthcare \u0026 Wellness\u003cSUP\u003eRx\u003c/SUP\u003e Trust",
      "end_date":"2020-06-10T00:00:00.000Z"
    }
  ]
}
